United States · FDA National Drug Code directory

Tizanidine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1799_eee9769d-c60c-477c-bad4-01b3acb68abc
Product NDC
71335-1799
Form
TABLET
Composition / generic term
Tizanidine
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20031211
Source listing expiry
20261231

Source-listed ingredients

  • TIZANIDINE HYDROCHLORIDE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 40 TABLET in 1 BOTTLE (71335-1799-0) · 71335-1799-0
  • 30 TABLET in 1 BOTTLE (71335-1799-1) · 71335-1799-1
  • 60 TABLET in 1 BOTTLE (71335-1799-2) · 71335-1799-2
  • 90 TABLET in 1 BOTTLE (71335-1799-3) · 71335-1799-3
  • 120 TABLET in 1 BOTTLE (71335-1799-4) · 71335-1799-4
  • 100 TABLET in 1 BOTTLE (71335-1799-5) · 71335-1799-5
  • 84 TABLET in 1 BOTTLE (71335-1799-6) · 71335-1799-6
  • 28 TABLET in 1 BOTTLE (71335-1799-7) · 71335-1799-7
  • 21 TABLET in 1 BOTTLE (71335-1799-8) · 71335-1799-8
  • 160 TABLET in 1 BOTTLE (71335-1799-9) · 71335-1799-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →